326 related articles for article (PubMed ID: 24703573)
21. Coexpression of NOR1 and SIX3 proteins in extraskeletal myxoid chondrosarcomas without detectable NR4A3 fusion genes.
Hisaoka M; Okamoto S; Yokoyama K; Hashimoto H
Cancer Genet Cytogenet; 2004 Jul; 152(2):101-7. PubMed ID: 15262426
[TBL] [Abstract][Full Text] [Related]
22. Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.
Stacchiotti S; Ferrari S; Redondo A; Hindi N; Palmerini E; Vaz Salgado MA; Frezza AM; Casali PG; Gutierrez A; Lopez-Pousa A; Grignani G; Italiano A; LeCesne A; Dumont S; Blay JY; Penel N; Bernabeu D; de Alava E; Karanian M; Morosi C; Brich S; Dagrada GP; Vallacchi V; Castelli C; Brenca M; Racanelli D; Maestro R; Collini P; Cruz J; Martin-Broto J
Lancet Oncol; 2019 Sep; 20(9):1252-1262. PubMed ID: 31331701
[TBL] [Abstract][Full Text] [Related]
23. A novel fusion variant LSM14A::NR4A3 in extraskeletal myxoid chondrosarcoma.
Ngo C; Verret B; Vibert J; Cotteret S; Levy A; Pechoux CL; Haddag-Miliani L; Honore C; Faron M; Quinquis F; Cesne AL; Scoazec JY; Pierron G
Genes Chromosomes Cancer; 2023 Jan; 62(1):52-56. PubMed ID: 35932215
[TBL] [Abstract][Full Text] [Related]
24. NR4A3 rearrangement reliably distinguishes between the clinicopathologically overlapping entities myoepithelial carcinoma of soft tissue and cellular extraskeletal myxoid chondrosarcoma.
Flucke U; Tops BB; Verdijk MA; van Cleef PJ; van Zwam PH; Slootweg PJ; Bovée JV; Riedl RG; Creytens DH; Suurmeijer AJ; Mentzel T
Virchows Arch; 2012 Jun; 460(6):621-8. PubMed ID: 22569967
[TBL] [Abstract][Full Text] [Related]
25. Primary extraskeletal myxoid chondrosarcoma of bone: Report of three cases and review of the literature.
Finos L; Righi A; Frisoni T; Gambarotti M; Ghinelli C; Benini S; Vanel D; Picci P
Pathol Res Pract; 2017 May; 213(5):461-466. PubMed ID: 28249774
[TBL] [Abstract][Full Text] [Related]
26. Response to sunitinib malate in advanced alveolar soft part sarcoma.
Stacchiotti S; Tamborini E; Marrari A; Brich S; Rota SA; Orsenigo M; Crippa F; Morosi C; Gronchi A; Pierotti MA; Casali PG; Pilotti S
Clin Cancer Res; 2009 Feb; 15(3):1096-104. PubMed ID: 19188185
[TBL] [Abstract][Full Text] [Related]
27. INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma.
Yoshida A; Makise N; Wakai S; Kawai A; Hiraoka N
Mod Pathol; 2018 May; 31(5):744-752. PubMed ID: 29327709
[TBL] [Abstract][Full Text] [Related]
28. Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study.
Antonescu CR; Argani P; Erlandson RA; Healey JH; Ladanyi M; Huvos AG
Cancer; 1998 Oct; 83(8):1504-21. PubMed ID: 9781944
[TBL] [Abstract][Full Text] [Related]
29. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma.
Wang WL; Mayordomo E; Czerniak BA; Abruzzo LV; Dal Cin P; Araujo DM; Lev DC; López-Terrada D; Lazar AJ
Mod Pathol; 2008 Nov; 21(11):1303-10. PubMed ID: 18587326
[TBL] [Abstract][Full Text] [Related]
30. Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect.
Stacchiotti S; Negri T; Zaffaroni N; Palassini E; Morosi C; Brich S; Conca E; Bozzi F; Cassinelli G; Gronchi A; Casali PG; Pilotti S
Ann Oncol; 2011 Jul; 22(7):1682-1690. PubMed ID: 21242589
[TBL] [Abstract][Full Text] [Related]
31. Identification of Novel PGR-NR4A3 Fusion in Extraskeletal Myxoid Chondrosarcoma and Resultant Patient Benefit From Tamoxifen Therapy.
Wilbur HC; Robinson DR; Wu YM; Kumar-Sinha C; Chinnaiyan AM; Chugh R
JCO Precis Oncol; 2022 Aug; 6():e2200039. PubMed ID: 36103645
[No Abstract] [Full Text] [Related]
32. Double-blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma.
Grivas PD; Daignault S; Tagawa ST; Nanus DM; Stadler WM; Dreicer R; Kohli M; Petrylak DP; Vaughn DJ; Bylow KA; Wong SG; Sottnik JL; Keller ET; Al-Hawary M; Smith DC; Hussain M
Cancer; 2014 Mar; 120(5):692-701. PubMed ID: 24249435
[TBL] [Abstract][Full Text] [Related]
33. Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma.
Morioka H; Takahashi S; Araki N; Sugiura H; Ueda T; Takahashi M; Yonemoto T; Hiraga H; Hiruma T; Kunisada T; Matsumine A; Susa M; Nakayama R; Nishimoto K; Kikuta K; Horiuchi K; Kawai A
BMC Cancer; 2016 Jul; 16():479. PubMed ID: 27418251
[TBL] [Abstract][Full Text] [Related]
34. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.
Panagopoulos I; Mertens F; Isaksson M; Domanski HA; Brosjö O; Heim S; Bjerkehagen B; Sciot R; Dal Cin P; Fletcher JA; Fletcher CD; Mandahl N
Genes Chromosomes Cancer; 2002 Dec; 35(4):340-52. PubMed ID: 12378528
[TBL] [Abstract][Full Text] [Related]
35. Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor.
Prior JO; Montemurro M; Orcurto MV; Michielin O; Luthi F; Benhattar J; Guillou L; Elsig V; Stupp R; Delaloye AB; Leyvraz S
J Clin Oncol; 2009 Jan; 27(3):439-45. PubMed ID: 19064982
[TBL] [Abstract][Full Text] [Related]
36. Extraskeletal myxoid chondrosarcoma of the vulva with PLAG1 gene activation: molecular genetic characterization of 2 cases.
Dotlic S; Gatalica Z; Wen W; Ghazalpour A; Mangham C; Babic D; Zekan J; Vranic S
Appl Immunohistochem Mol Morphol; 2014 Aug; 22(7):537-42. PubMed ID: 24185117
[TBL] [Abstract][Full Text] [Related]
37. CHRNA6 RNA In Situ Hybridization Is a Useful Tool for the Diagnosis of Extraskeletal Myxoid Chondrosarcoma.
Dulken BW; Kingsley L; Zdravkovic S; Cespedes O; Qian X; Suster DI; Charville GW
Mod Pathol; 2024 May; 37(5):100464. PubMed ID: 38447752
[TBL] [Abstract][Full Text] [Related]
38. Identification of genes regulated by the EWS/NR4A3 fusion protein in extraskeletal myxoid chondrosarcoma.
Filion C; Labelle Y
Tumour Biol; 2012 Oct; 33(5):1599-605. PubMed ID: 22592656
[TBL] [Abstract][Full Text] [Related]
39. Molecular and Clinicopathologic Heterogeneity of Intracranial Tumors Mimicking Extraskeletal Myxoid Chondrosarcoma.
Velz J; Agaimy A; Frontzek K; Neidert MC; Bozinov O; Wagner U; Fritz C; Coras R; Hofer S; Bode-Lesniewska B; Rushing E
J Neuropathol Exp Neurol; 2018 Aug; 77(8):727-735. PubMed ID: 29924341
[TBL] [Abstract][Full Text] [Related]
40. Intraluminal EWSR1-CREB1 gene rearranged, low-grade myxoid sarcoma of the pulmonary artery resembling extraskeletal myxoid chondrosarcoma (EMC).
Opitz I; Lauk O; Schneiter D; Ulrich S; Maisano F; Weder W; Bode-Lesniewska B
Histopathology; 2019 Feb; 74(3):526-530. PubMed ID: 30326150
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
